文献速递肾移植

尿液蛋白标志物组合用于诊断肾移植受者抗体介导排斥反应

Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients.
PubMed 文献 · Kidney Int Rep · 2020-06-29

本研究通过多中心病例对照训练队列(n=249)和独立前瞻性多中心验证队列(n=391),基于Banff分类活检结果,采用非靶向蛋白鉴定与支持向量机建模,识别出10种尿液蛋白可准确区分抗体介导排斥反应(ABMR)。训练队列AUC为0.98(95%CI 0.96-1.00),验证队列AUC为0.88(95%CI 0.8-0.93),阴性预测值0.99,阳性预测值0.33,诊断准确性优于大量蛋白尿(AUC 0.76)。该标志物组合可用于排除ABMR。

要点

  • 10种尿液蛋白组合诊断ABMR验证队列AUC为0.88(95%CI 0.8-0.93)。
  • 该标志物组合阴性预测值0.99,适用于排除ABMR。
  • 诊断准确性独立于活检原因和移植后时间,优于大量蛋白尿。

核心结论

  • 识别并验证了一组尿液蛋白标志物,可用于排除肾移植受者的抗体介导排斥反应。

研究设计与样本

  • 多中心病例对照研究用于训练(n=249),独立前瞻性多中心队列用于验证(n=391),依据Banff分类对同期活检样本进行分类。

主要发现

  • 训练队列中10种尿液蛋白区分ABMR(n=60)与非ABMR(n=189)的AUC为0.98(95%CI 0.96-1.00)。
  • 验证队列中区分ABMR(n=43)与非ABMR(n=348)的AUC为0.88(95%CI 0.8-0.93)。
  • 该10蛋白标志物组合排除ABMR的阴性预测值为0.99,阳性预测值为0.33。
  • 诊断准确性独立于活检原因和移植后时间,且优于大量蛋白尿(AUC 0.76)。

关键数值与推荐

  • 训练队列AUC 0.98(95%CI 0.96-1.00),验证队列AUC 0.88(95%CI 0.8-0.93)。
  • 阴性预测值0.99,阳性预测值0.33。
  • 大量蛋白尿AUC 0.76。

临床怎么用

  • 该尿液蛋白标志物组合可用于无创排除ABMR,减少不必要的移植肾活检。
  • 阳性预测值较低,阳性结果仍需活检确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Antibody-mediated rejection (ABMR) impacts kidney allograft outcome. The diagnosis is made based on findings from invasive kidney transplant biopsy specimens. The aim of this study was to identify a noninvasive urinary protein biomarker for ABMR after kidney transplantation. METHODS: We performed a multicenter case-control study to identify a urinary biomarker for ABMR (training cohort, n = 249) and an independent, prospective multicenter cohort study for validation (n = 391). We used concomitant biopsies to classify the samples according to the Banff classification. After untargeted protein identification and quantification, we used a support vector machine to train the model in the training cohort. The primary endpoint was the diagnostic accuracy of the urinary biomarker for ABMR in the validation cohort. RESULTS: We identified a set of 10 urinary proteins that accurately discriminated patients with (n = 60) and without (n = 189) ABMR in the training cohort with an area under the curve (AUC) of 0.98 (95% confidence interval [CI], 0.96-1.00). The diagnostic accuracy was maintained in the validation cohort (AUC, 0.88; 95% CI, 0.8-0.93) for discriminating the presence (n = 43) from the absence (n = 348) of ABMR. The negative predictive value of the 10-protein marker set for exclusion of ABMR was 0.99, and the positive predictive value was 0.33. The diagnostic accuracy was independent of the reason for performing the biopsy, time after transplantation, and better than the accuracy of gross proteinuria (AUC, 0.76). CONCLUSIONS: We identified and validated a urinary protein biomarker set that can be used to exclude ABMR.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Mertens I, Willems H, Van Loon E, et al. Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients. Kidney Int Rep. 2020. PMID: 32954069. doi:10.1016/j.ekir.2020.06.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。